Cary Street Partners Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Cary Street Partners Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.52M	Buy	5,684 +346	+6%	+$205K	0.46%	55
2024 Q2	$2.95M	Buy	5,338 +66	+1%	+$37.8K	0.43%	62
2024 Q1	$3.06M	Buy	5,272 +44	+0.8%	+$24.7K	0.48%	53
2023 Q4	$2.77M	Buy	5,228 +1,467	+39%	+$710K	0.48%	59
2023 Q3	$1.9M	Buy	3,761 +46	+1%	+$24.5K	0.36%	75
2023 Q2	$1.94M	Sell	3,715 -95	-2%	-$51.3K	0.36%	75
2023 Q1	$2.2M	Sell	3,810 -160	-4%	-$90.2K	0.42%	64
2022 Q4	$2.19M	Buy	3,970 +93	+2%	+$49.3K	0.44%	59
2022 Q3	$1.97M	Buy	3,877 +53	+1%	+$29.7K	0.47%	54
2022 Q2	$2.08M	Sell	3,824 -21	-0.5%	-$11.6K	0.49%	57
2022 Q1	$2.27M	Sell	3,845 -3	-0.1%	-$1.72K	0.45%	59
2021 Q4	$2.57M	Sell	3,848 -38	-1%	-$23.7K	0.55%	50
2021 Q3	$2.22M	Sell	3,886 -113	-3%	-$62K	0.78%	43
2021 Q2	$2.02M	Sell	3,999 -67,330	-94%	-$31.8M	0.48%	64
2021 Q1	$2.06M	Buy	71,329 +4,503	+7%	+$2.15M	0.51%	62
2020 Q4	$1.9M	Buy	+66,826	New	+$31.3M	0.56%	56

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cary Street Partners Asset Management's TMO Position: Q3 2024 in Review

Cary Street Partners Asset Management increased its Thermo Fisher Scientific (TMO) stake by 6.5% in Q3 2024, buying an estimated $205K and bringing the position to 5,684 shares worth $3.52M. The position accounts for 0.46% of the portfolio, ranked #55.

Cary Street Partners Asset Management first reported a position in TMO in Q4 2020 and has held it in 16 quarters since. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Cary Street Partners Asset Management held 5,684 shares of Thermo Fisher Scientific worth $3.52M as of Q3 2024.
Cary Street Partners Asset Management bought 346 Thermo Fisher Scientific shares in Q3 2024, an estimated $205K.
Thermo Fisher Scientific made up 0.46% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #55 holding.
Cary Street Partners Asset Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 16 quarters since.
2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.